XML 57 R42.htm IDEA: XBRL DOCUMENT v3.22.2

Loss Per Common Share (Tables)

6 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Computation of basic and diluted earnings per share

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):

			For the Three Months Ended June 30,												For the Six Months Ended June 30,
			2022						2021						2022						2021
Loss from continuing operations			$	(4,125)					$	(9,107)					$	(9,475)					$	(20,297)
Income (loss) from discontinued operations, net of tax			(463)						—						(463)						1,383
Net loss attributable to common shareholders of Evolent Health, Inc.			$	(4,588)					$	(9,107)					$	(9,938)					$	(18,914)
Weighted-average common shares outstanding - basic and diluted			90,071						85,448						89,792						85,056
Loss per common share
Basic and diluted
Continuing operations			$	(0.05)					$	(0.11)					$	(0.11)					$	(0.24)
Discontinued operations			—						—						—						0.02
Basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc.			$	(0.05)					$	(0.11)					$	(0.11)					$	(0.22)

Schedule of antidilutive securities excluded from computation of earnings per share

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):

			For the Three Months Ended June 30,												For the Six Months Ended June 30,
			2022						2021						2022						2021
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")			1,642						2,052						1,817						1,793
Stock options			1,852						1,801						1,807						1,833
Convertible senior notes			11,582						12,696						11,582						12,696
Total			15,076						16,549						15,206						16,322

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration